. Author manuscript; available in PMC: 2009 Jan 1.

Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Jan;49(1):372–379. doi: 10.1167/iovs.07-0952

Table 1.

Mean Rheobase and Chronaxie Values Extrapolated from Strength-Duration Curves with Correlations of Linear Approximation

	10 ng/day CNTF		1 ng/day CNTF		PBS		Untreated Controls
	Treated	Untreated	Treated	Untreated	Treated	Untreated	OQ	OS
Baseline
Rheobase	5.00 ± 1.04	5.06 ± 1.63	3.40 ± .81	3.05 ± .83	5.29 ± 1.23	6.51 ± 1.85	11.02 ± 4.18	9.69 ± 2.67
Chronaxie	4.29 ± 1.24	3.80 ± .98	3.32 ± 2.18	1.82 ± .83	3.36 ± .83	1.73 ± .45	3.58 ± .83	3.23 ± .76
Model fit: R²	0.93 ± .02	0.95 ± .02	0.96 ± .02	0.97 ± .02	0.94 ± .01	0.95 ± .01	0.96 ± .01	0.96 ± .02
Postoperative Week 3
Rheobase	10.73 ± 3.53	19.84 ± 7.38	14.42 ± 6.61	16.05 ± 8.38	16.43 ± 2.59	18.86 ± 4.61	27.62 ± 7.21	39.78 ± 14.33
Chronaxie	2.68 ± .75	1.95 ± .87	1.45 ± .26	1.96 ± .75	3.52 ± .74	2.84 ± .70	3.53 ± 1.19	2.32 ± .35
Model fit: R²	0.96 ± .01	0.91 ± .01	0.97 ± .01	0.96 ± .01	0.96 ± .01	0.94 ± .01	0.95 ± .02	0.97 ± .01

Data are expressed as the mean ± SEM.